Inactive Instrument

Calendar BICYCL Nasdaq

Equities

US0887861088

Chart calendar BICYCL

98ae169e7c520464e2f20616854574c1.H8qa9AW0Nj7zZwQbJORaI2Bn4afjQt05GuSPPske5xw.ab3phXflBlahIU95cKU5cQwQruapEplccKa_S6ItvypeiM2Tc-5Oe4tXRQ~01e54e23022ab03c68a5f4a8268baee8

Upcoming events on BICYCL

13/05/2024 14:00 Citizens JMP Life Sciences Conference
16/05/2024 14:00 Annual General Meeting
01/06/2024 15:00 American Society of Clinical Oncology Annual Meeting - Abstract Number: 3088
02/06/2024 15:00 American Society of Clinical Oncology Annual Meeting - Abstract Number: TPS4619
31/07/2024 Q2 2024 Earnings Release (Projected)
30/10/2024 Q3 2024 Earnings Release (Projected)
03/03/2025 Q4 2024 Earnings Release (Projected)
30/04/2025 Q1 2025 Earnings Release (Projected)

Past events on BICYCL

02/05/2024 12:00 Q1 2024 Earnings Release
09/04/2024 21:30 American Association for Cancer Research Meeting - Abstract Number: 5807
09/04/2024 21:30 American Association for Cancer Research Meeting - Abstract Number: 5301
09/04/2024 16:00 Needham Healthcare Conference
08/04/2024 17:00 American Association for Cancer Research Meeting - Abstract Number: 1340
14/03/2024 12:30 Barclays Global Healthcare Conference - Fireside Chat
11/03/2024 16:00 Leerink Partners Global Biopharma Conference
06/03/2024 16:10 TD Cowen Health Care Conference - Fireside Chat
20/02/2024 12:05 Q4 2023 Earnings Release
14/02/2024 15:00 Oppenheimer Healthcare Life Sciences Conference
18/01/2024 16:00 B. Riley Securities Oncology Conference - Track 1
14/12/2023 13:00 R&D Day
15/11/2023 10:00 Jefferies London Healthcare Conference - Fireside Chat
03/11/2023 14:00 TD Cowen Fall Oncology Innovation Summit - Fireside Chat
02/11/2023 11:00 Q3 2023 Earnings Release
12/09/2023 15:10 Morgan Stanley Global Healthcare Conference - Fireside Chat
11/09/2023 13:00 BT8009 Phase 2/3 Study Results Call
03/08/2023 11:59 Q2 2023 Earnings Release
20/06/2023 17:30 TD Cowen Radiopharmaceutical Innovation Summit
13/06/2023 12:00 Annual General Meeting

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD
Released
Forecast
Spread
13,8
9,99
38.18%
10,4
9,30
11.76%
11,7
13,3
-12.02%
14,5
14,9
-2.74%
27,0
29,9
-9.73%

38,3

EBITDA
Million USD
Released
Forecast
Spread
-25,3
-27,3
7.21%
-50,7
-36,3
-39.65%
-64,2
-62,3
-3.14%
-113
-112
-0.47%
-183
-167
-9.85%

-192

EBIT
Million USD
Released
Forecast
Spread
-26,3
-30,6
14.04%
-52,0
-44,9
-15.6%
-65,6
-64,4
-1.96%
-117
-116
-0.62%
-190
-187
-1.43%

-210

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-30,9
-34,1
9.41%
-51,7
-45,4
-13.83%
-68,5
-66,9
-2.38%
-114
-116
1.5%
-179
-185
3.2%

-201

Net income
Million USD
Released
Forecast
Spread
-30,6
-34,0
9.98%
-51,0
-44,9
-13.62%
-66,8
-65,6
-1.82%
-113
-115
1.96%
-181
-185
2.56%

-193

EPS
USD
Released
Forecast
Spread
-2,77
-2,31
-19.74%
-2,66
-2,31
-14.94%
-2,67
-2,69
0.71%
-3,80
-3,85
1.38%
-5,08
-5,32
4.56%

-4,51

Announcement Date10/03/2011/03/2101/03/2228/02/2320/02/24-

Quarterly results

Fiscal PeriodDecember 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales
Million USD
Released
Forecast
Spread
3,86
4,41
-12.49%
4,38
3,69
18.7%
3,04
5,58
-45.51%
3,19
3,55
-10.37%
4,90
7,72
-36.59%
11,4
12,9
-11.79%
5,35
13,8
-61.12%
5,33
6,88
-22.48%
19,5
6,03
223.7%

6,04


5,97


6,63


6,53


7,09

EBIT
Million USD
Released
Forecast
Spread
-27,4
-19,1
-43.25%
-27,3
-24,8
-9.89%
-29,8
-27,0
-10.29%
-32,2
-31,5
-2.25%
-41,8
-26,2
-59.63%
-43,1
-31,3
-37.82%
-50,8
-42,4
-19.78%
-54,2
-53,4
-1.48%
-31,7
-55,0
42.37%

-53,3


-58,8


-66,8


-59,5


-61,2

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-28,0
-19,4
-43.91%
-27,3
-25,5
-6.87%
-28,6
-27,5
-3.93%
-30,4
-32,1
5.38%
-39,7
-32,4
-22.39%
-43,1
-29,6
-45.66%
-47,6
-41,6
-14.43%
-48,8
-54,5
10.56%
-26,9
-55,1
51.18%

-51,1


-57,9


-64,7


-58,6


-59,8

Net income
Million USD
Released
Forecast
Spread
-27,6
-19,7
-40.1%
-26,8
-25,2
-6.48%
-28,3
-28,1
-0.79%
-30,0
-32,1
6.54%
-39,1
-32,3
-20.9%
-42,6
-30,8
-38.3%
-49,9
-42,1
-18.48%
-49,1
-53,5
8.21%
-26,6
-54,0
50.8%

-49,1


-55,5


-61,7


-58,6


-59,8

EPS
USD
Released
Forecast
Spread
-0,93
-0,67
-39.01%
-0,90
-0,86
-4.43%
-0,96
-0,91
-6.08%
-1,01
-1,07
5.83%
-1,30
-1,08
-20.18%
-1,41
-1,02
-37.67%
-1,26
-1,13
-11.15%
-1,16
-1,31
11.27%
-0,62
-1,28
51.64%

-1,15


-1,30


-1,43


-1,35


-1,37

Announcement Date05/05/2204/08/2203/11/2228/02/2304/05/2303/08/2302/11/2320/02/2402/05/24-----